NEKTAR THERAPEUTICS — Director's Dealing 2017

Jul 19, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NEKTAR THERAPEUTICS (NKTR)
CIK: 0000906709
Period of Report: 2017-07-14

Reporting Person: Lingnau Lutz (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-07-14	Common Stock	M	30000	$14.26	Acquired	53450	Direct
2017-07-14	Common Stock	S	30000	$20.76	Disposed	23450	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-07-14	Stock Option	$14.26	M	30000	Disposed	2018-09-13	Common Stock (30000)	Direct

Footnotes

F1: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: This transaction was executed in multiple trades at prices ranging from $20.40 to $20.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and the prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer.